Dendreon stock outlook feb 27 2012

Dendreon stock outlook feb 27 2012 : Dendreon Corporation (NASDAQ: DNDN) has estimates of -0.23 EPS and $119.8-M in revenue. Shares are trading around 15.00 and above the mean consensus target of 12.82 from analysts but still down about 50% from its 52-wk high, and up over 100% from its 52-wk low.

This is all about the adoption of PROVENGE from doctors, and it is expected to come back on track. Look at guidance closely; estimates for Y 2012 earnings are 1.61 EPS on $392.6-M in sales.

For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post: